• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM-OUTFLOW GRAFT; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM-OUTFLOW GRAFT; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 1125
Device Problems Device Damaged Prior to Use (2284); Cut In Material (2454)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/12/2018
Event Type  malfunction  
Manufacturer Narrative
This device is used for treatment not diagnosis.The ventricular assist system is indicated for use as a bridge to cardiac transplantation and destination therapy in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that after prepping the pump on the back table, before it was implanted, it was noted that there was a leak and associated tear in the outflow graft.It was stated that ¿nothing abnormal was done during pump prep¿.It was further stated that the torn section was trimmed off of the outflow graft and pump was re-assembled and there were no further issue and pump was implanted in normal fashion.No patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Product event summary: the outflow graft, lot 16347637-0361, was not returned for evaluation.A review of the manufacturing documentation confirmed that the associate outflow graft met all requirements for release.Visual evidence provided by the site revealed a tear in the outflow graft, thus confirming the reported event.An investigation was initiated to investigate tears in the outflow graft.Based on this investigation, the most likely root cause of tears or cuts in the outflow graft has been attributed to design issues.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Supplemental mdr report is being submitted to include the associated fda z-number issued for the reported issue captured in this report.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTWARE VENTRICULAR ASSIST SYSTEM-OUTFLOW GRAFT
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
HEARTWARE, INC.
14400 nw 60th ave
miami lakes FL 33014
MDR Report Key7303106
MDR Text Key101482671
Report Number3007042319-2018-00867
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00888707000222
UDI-Public00888707000222
Combination Product (y/n)N
PMA/PMN Number
P100047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 06/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/31/2022
Device Model Number1125
Device Catalogue Number1125
Was Device Available for Evaluation? No
Date Manufacturer Received05/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-2058-2020
Patient Sequence Number1
Treatment
1103 VAD
Patient Age55 YR
Patient Weight113
-
-